Dipivefrin (Insignis Therapeutics)

N/A

Report date: 2025/03/11 17:16:27

Base Information

Drug NameDipivefrin (Insignis Therapeutics)
Drug Alias NameEpinephrine prodrug (Insignis Therapeutics)IN-001HLK-0006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsFood HypersensitivityAnaphylaxis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInsignis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInsignis Therapeutics IncHLK Pharmacin LLC
Inactive CompaniesN/A
Active IndicationsFood HypersensitivityAnaphylaxis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A